The post On-Chain Signals Point to Market Weakness: Short-Term Holders in Loss as Key Supports Flip to Resistance (CryptoQuant’s Axel) appeared on BitcoinEthereumNewsThe post On-Chain Signals Point to Market Weakness: Short-Term Holders in Loss as Key Supports Flip to Resistance (CryptoQuant’s Axel) appeared on BitcoinEthereumNews

On-Chain Signals Point to Market Weakness: Short-Term Holders in Loss as Key Supports Flip to Resistance (CryptoQuant’s Axel)

CryptoQuant’s data, highlighted by analyst Axel on social media, indicates a cautious backdrop for the crypto market, as both market sentiment and on-chain structure align toward weakness. The analysis shows short-term holders are already in the red, and several key support levels have shifted into resistance, suggesting looming headwinds for near-term valuations. Traders should monitor liquidity taps and risk-off moves as the confluence of sentiment deterioration and on-chain signals reinforces a selective risk posture. While data remain non-committal on a durable trend, the alignment of these metrics underscores the importance of disciplined risk controls and sector-leading indicators for informed positioning.

Source: https://en.coinotag.com/breakingnews/on-chain-signals-point-to-market-weakness-short-term-holders-in-loss-as-key-supports-flip-to-resistance-cryptoquants-axel

Market Opportunity
RedStone Logo
RedStone Price(RED)
$0.2104
$0.2104$0.2104
-2.77%
USD
RedStone (RED) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.